How Does Calcium Lower the Risk of Colon Cancer?

Calcium supplementation protect against the most dangerous types of colon polyps, and therefore colorectal cancer, as reported by the Journal of the National Cancer Institute.Intestinal tract polyps are growths that develop inside the large intestine. Most have the capabilities to become cancer, with large polyps or those who show a high degree of cancerous changes the most likely to progress. Colon cancer is the second most widespread cancer in Western countries. People with family members who definitely have had digestive tract melanoma, and people who have inflammatory bowel disease, just like Crohn’s disorder and ulcerative colitis, are at higher threat for colon cancer. Familial polyposis, and hereditary condition distinguished by frequent formation of colon polyps, also increases the risk of colorectal cancer.

A wide range of dietary factors might give rise to colon cancer risk. A diet that is rich in vegetables appears to be the most safety. In contrast, eating deep fried or darkly browned meat foods frequently more than, enhances the possibility of cancer of the intestinal system, obviously because cancer-causing chemicals form during high-temperature cooking of meat. Some analysis have found that increasing fiber can avoid cancer of the intestinal system, but other analysis have did not validate those reports. Wide ranges of analysis have suggested that calcium might avoid cancer of the intestinal system. Some, but not all, have found that taking calcium supplements can lower the possibility of developing cancer of the intestinal system and precancerous polyps.

In the existing analysis, 913 people who had at least one colon polyp operatively removed. They all had the surgery treatment within three a few weeks before coming into the analysis, and were polyp-free upon entry. Healthy intake of calcium, fat, and fiber was analyzed for each person through the use of foods related concerns, and each was then randomly assigned to get either 1,200 mg of calcium carbonate per day or placebo. Colonoscopic exams to look for new polyps were performed one and four years after the start of the analysis, and polyps that were found were analyzed to determine their type, size, and level of melanoma change. At the end of the analysis, the possibility of developing intestinal system polyps was found to be 14% decreased in people taking calcium than in those taking placebo. Moreover, calcium supplement lower the possibility of the most serious kinds of intestinal system polyps by 35%.

The results of this analysis suggest that supplementing with calcium might offer some protection against precancerous colon polyps in people at higher risk due to a previous history of polyps. They further show that polyps that developed while getting calcium might be less likely to be the most serious type. Future analyses are required to confirm these results. For now, it is cost-effective to suggest calcium supplements to those who are at higher risk of developing intestinal system polyps.

Blood Test a Possibility for Colon Cancer Screening

For the field of cancer analysis, an efficient blood evaluation for colon melanoma would be an exposure. Currently, the condition is medically diagnosed through stool blood test and distressing colonoscopies, but the dream is to be able to find genetic signs predictive of such malignancies in order to get intervene early or follow sufferers in their treatment.
An analysis released Friday in the Journal of Molecular Diagnostics indicates that a blood evaluation for melanoma of the colon could be on the horizon. But the analysis is still preliminary and the evaluation is not currently recommended as an examining tool, said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.  The life-time risk of developing colon melanoma is 1 in 20, and men are a little bit more likely to get it than women, according to the America Cancer Group. In 2013, it is expected to cause more than 50,000 deaths.

The Study

Researchers at Genomictree, Inc., and the Yonsei University College of Medicine in Seoul, South Korea, first went on a "search mission" to find genes that could be related to colon melanoma tissues, Lichtenfeld said. They compared growth tissues illustrations from sufferers to non-tumor tissues, and identified candidate genes that could be signs for melanoma of the colon. They targeted on one for further analysis, a tagging called SDC2.
Then, scientists took blood illustrations from 12 colon cancer sufferers with various levels of melanoma, to look for that gene. They found that this gene was present, and could be identified, in the patients' blood. In these sufferers, the gene was predictive for melanoma of the colon.

Bigger Picture

The ultimate goal of this line of analysis is to find a blood evaluation that would either find out cancer early or help doctors follow sufferers in their treatment to see how it's working, Lichtenfeld said. This analysis has exposed that this particular gene may be a tagging that could be useful in either following melanoma of the colon sufferers, or possibly defining melanoma of the colon early and saving lives, he said. Eventually, however, doctors want to be able to recognize a lesion before it becomes melanoma, Lichtenfeld said. The authors of this analysis not claim that this blood evaluation will do that. It's unknown whether this particular evaluation would find out melanoma of the colon early enough to save way of life or prevent people from developing the disease, Lichtenfeld said. More analysis needs to be done.

Other Candidates

This isn't the only potential tagging for melanoma of the colon that a blood evaluation could pick up. There are other genes that other analysis groups are looking at, too. Research authors had written that their results are similar to those of the SEPT9 evaluation for colon melanoma. SEPT9 is a gene that has also been associated with the scenario. A 2011 analysis in the publication BMC Drugs exposed the potential for that gene to serve as a tagging in a blood evaluation for colon melanoma - but this analysis is not specified either. "No efficient company is indicating that either of these tests be used as examining evaluation for melanoma of the colon," Lichtenfeld said. The SEPT9 evaluate is being marketed with claims that it could alternative a colonoscopy, but the America Cancer Group does not recommend it presently, Lichtenfeld said.

Source: http://bit.ly/1bnKh0D

Does Intestinal Obstruction Links To Colon Cancer?

In an abdominal obstruction (intestinal obstruction), an impediment prevents the content of the intestinal system from shifting normally through the digestive system. The problem causing the impediment can be within or outside the intestine. Inside the intestine, a development or inflammation can fill and block the inside passage of the intestine. Outside the intestine, it is possible for a nearby body organ or place of cells to pinch, compress or twist a segment of bowel.

An abdominal obstacle can occur in the digestive tract (small intestine) or large abdominal (large abdominal or colon). Also, a bowel obstruction can be total or limited, based on whether any stomach content can pass through the blocked place.

Intestinal obstruction or impediment of the intestine in the digestive tract is incapacity of the abdominal stomach pain, feeling sick, green vomit and fecal vomiting(feces-like vomit) as well as bowel problems, lack of ability to release waste, blood-stained mucous or shifting jelly-like mucous and shock. When there is impediment in the large or small intestine system, the obstacle in the large abdominal program can cause to melanoma of the colon. The large intestine is composed of the colon as well as the rectum. The colon is the part where stool is formed while the rectum is the part of the excretory system that dumps it outside the body via the anal canal. For blockage happening in the small intestines, it called small bowel obstruction while blockage in the colon is referred to as colonic obstruction.program or simply an arrest of the passing of content through the abdominal. This results to gas such as "crampy"

There are several causes of stomach obstruction. The three most typical are adhesions, hernias and melanoma cancers. Adhesions are groups of scars that form in the stomach after an injury or surgery treatment. Hernia produces when an element of the abdominal protrudes to a poor spot in the stomach wall.

Intestinal obstruction can also be a consequence of volvulus, the presence of foreign particles in the abdominal program, intussusception, genetic problems and infection. Intestinal obstacle of the abdominal program or colonic obstacle is less typical as compared to obstacles in the small abdominal program. Obstruction of large intestine is usually caused by melanoma of the colon.

While obstruction of the small abdominal program can be treated with IV fluids and bowel decompression, for melanoma of the abdominal program, treatments are already necessary. If ignored for lengthy stretches, it can cause to death. This is why proper analysis for stomach obstruction is necessary as it may help extend your life. Billions cells made up our bodies. These cells grow, split and die. When something goes wrong to this program of cells, it can outcome to melanoma. It is melanoma that causes out of control development and cell department. These melanoma cells group together and type a mass of cells known as cancerous tumor. When melanoma cells are present in the abdominal program, of course, melanoma of the abdominal program becomes a risk to your living lifestyle.

Colon melanoma doesn't usually show signs or symptoms, except for stomach obstruction. Individuals with a genealogy of melanoma of the abdominal program are the ones who are more vulnerable to the condition. This also goes for those who long-standing ulcers. These risks, however, can be avoided by eating less fat and more fiber. Intestinal obstruction or its signs must not be taken gently. Seek immediate research such as assessments and stomach x-rays. Treatment includes fluid resuscitation, suction, nasogastric and, in most serious cases, surgery and chemotherapy.

Immunological Tests Superior in Colon Cancer Screening

Assessments for hidden records of blood in the feces offer signs to melanoma of the digestive tract or precancerous patches. For over 40 decades, an enzymatic recognition method has been used to identify the diseases. Now immunological tests have also become available. Epidemiologists from the German Cancer Research Center (DKFZ) compared the two methods and have proven the benefits of immunological tests. They identify more than twice as many melanoma cases and deliver fewer false positive outcomes.

For early recognition of intestinal tract (colon) melanoma, legal health insurance coverage in Germany offers endoscopic evaluation of the digestive tract (colonoscopy). Colonoscopy recognizes precancerous patches with an advanced level of exactitude. Nevertheless, only about 20-30 percent of those eligible actually take advantage of the testing evaluation. "Therefore, fecal occult blood examinations are essential, because they help us reach more individuals. Everyone is much more willing to have a simple lab analysis. Hence it is all the more essential for these tests to offer valuable outcomes," says Lecturer Hermann Brenner from the German Cancer Research Center.
a fecal occult blood analysis absolutely free to all insured persons starting at 50 year of age. In addition, those 55 or older are entitled to an

The evaluation protected by health insurance coverage is in accordance with the recognition of enzymatic action in fecal occult blood (a "stool guaiac test"). For several years now, immunological examining techniques using antibodies to identify hemoglobin in feces examples have also been available. These assessments are considered as more sensitive; i.e., they are considered to identify more cells irregularities. Until now, however, the two techniques have only been compared in a few small-scale researches.

Hermann Brenner and his colleague Sha Tao have now compared the two techniques in a large-scale study for the first time. 2,235 members who experienced colon cancer evaluating colonoscopies between 2005 and 2009 offered feces examples instantly prior to the evaluation. These were examined for occult blood using both techniques. Consequently, the DKFZ scientists examined the test outcomes by evaluating them with the outcomes from colonoscopies. The enzyme-based analyze recognized one third of all melanoma of the digestive tract cases, about 9 % of innovative precancerous patches (adenomas), and about 5 % of early precancerous patches. The uniqueness was a little bit over 95%: In 95 out of 100 members with negative analyzes outcomes, no cells irregularities were found in the following colonoscopy.

However, the three immunological tests that were used recognized about twice as many melanoma cases and about three times as many innovative precancerous patches, with a uniqueness that was a little greater than enzymatic examining. Only one third (31 percent) of all good outcomes from enzymatic examining were in fact caused by a cells problem. By evaluation, colonoscopy verified the presence of a problem in about sixty-six per cent (57 to 68 percent) of good outcomes acquired by immunological examining. "Immunological assessments can thus help persuade folks with a beneficial finding to get a colonoscopy afterwards, significance that those individuals who actually have precancerous patches would likely get involved in colonoscopy examining," describes Brenner.

The enzymatic analyze only provides a good or bad outcome, whereas the immunological analyze quantifies hemoglobin levels. The scientists therefore had to make the outcomes similar by interpreting threshold principles for the immunological assessments such that both methods provided the same variety of good outcomes. “For the first time we have shown by direct evaluation that the analytic performance of immunological feces assessments is considerably greater than that of the enzymatic analyze at the same rate of good outcomes," says Hermann Brenner. He desires that his research will provide an effective discussion to health-care policy creators. "Tests for occult blood in the feces will continue to be a significant part of melanoma of the digestive tract examining. We therefore suggest such as immunological assessments in melanoma examining applications in Malaysia. Many more individuals would thus benefit by acquiring a life-saving hint directing to an invisible case of melanoma."

In a number of European countries that provide melanoma examining applications, immunological assessments have already become the standard. Besides greater understanding, they provide further realistic advantages: They can be more easily computerized, and members do not have to avoid certain types of food prior to the analyze, because the antibodies respond specifically to human hemoglobin. Brenner is assured that the a little bit greater costs of immunological examining will fall once the assessments can be created on an extensive.